Development of semiautomated module for preparation of 131I labeled lipiodol for liver cancer therapy
dc.contributor.author | Mukherjee, A. | |
dc.contributor.author | Subramanian, S. | |
dc.contributor.author | Ambade, R. | |
dc.contributor.author | Avhad, B. | |
dc.contributor.author | Dash, A. | |
dc.contributor.author | Korde, A. | |
dc.date.accessioned | 2017-09-07T10:13:00Z | |
dc.date.available | 2017-09-07T10:13:00Z | |
dc.date.issued | 2017 | |
dc.description.division | RPhD | en |
dc.format.extent | 4692 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Cancer Biotherapy and Radiopharmaceuticals, 2017. Vol. 32 (1): pp. 33-37 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/14863 | |
dc.language.iso | en | en |
dc.subject | 131I labeled Lipiodol | en |
dc.subject | hepatocellular carcinoma | en |
dc.subject | liver cancer therapy | en |
dc.subject | radioembolization | en |
dc.subject | radiosynthesis | en |
dc.subject | semiautomated module | en |
dc.title | Development of semiautomated module for preparation of 131I labeled lipiodol for liver cancer therapy | en |
dc.type | Article | en |